Optex Systems (OPXS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
17 Feb, 2026Executive summary
Revenue increased 11.6% year-over-year to $9.1 million, driven by strong Optex Richardson growth and higher periscope and XM30 program demand, partially offset by a decline at the Applied Optics Center segment.
Net income was $0.2 million, down from $0.8 million in the prior year, mainly due to lower gross profit and higher G&A expenses, including non-recurring CEO transition costs.
Adjusted EBITDA for the quarter was $0.7 million, down from $1.1 million year-over-year.
Backlog stood at $37.9 million, a 9.8% decrease from the prior year, but order momentum remained strong with $7.9 million in new orders, up 31.7% year-over-year.
Gross margin declined to 22.9% from 26.0% year-over-year, impacted by legacy contracts, higher G&A, and gold price increases.
Financial highlights
Operating income dropped to $0.1 million from $0.9 million year-over-year.
Operating cash used was $0.1 million, compared to $2.8 million generated in the prior year period.
Cash and equivalents at quarter end were $5.8 million, with no outstanding credit line balance.
Working capital was $21.2 million as of December 28, 2025.
Basic EPS for the quarter was $0.04, down from $0.12 in the prior year.
Outlook and guidance
Management expects higher revenues and gross profits in the second half of fiscal 2026 as loss contracts conclude and new, higher-margin programs scale.
AOC revenues projected to recover as government appropriations resume.
Margins and profitability anticipated to improve sequentially, with long-term margins expected to align with prior year performance.
Expectation of net income and positive operating cash flow over the next nine months.
Capital investments and R&D spending to support new programs and revenue growth.
Latest events from Optex Systems
- Virtual annual meeting to elect directors and ratify auditor, with online voting available.OPXS
Proxy Filing20 Jan 2026 - Annual meeting to elect five directors and ratify auditor, with strong governance and ESG focus.OPXS
Proxy Filing20 Jan 2026 - Revenue and net income surged, backlog rebounded, and cash rose with strong contract wins.OPXS
Q3 20256 Jan 2026 - Strong revenue and profit growth, CEO transition, and order delays amid 2026 growth optimism.OPXS
Q4 202518 Dec 2025 - Annual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance.OPXS
Proxy Filing2 Dec 2025 - Revenue and net income surged, margins improved, and outlook remains strong with no debt.OPXS
Q1 20258 Oct 2025 - Revenue, profit, and backlog surged on military demand and operational gains; supply risks remain.OPXS
Q3 202410 Sep 2025 - Revenue and profit surged on periscope and laser filter demand, with strong cash flow and new contracts.OPXS
Q2 202510 Sep 2025 - Revenue up 32.5% and net income up 66.5% year-over-year, with strong backlog growth.OPXS
Q4 202410 Sep 2025